Compare LFMD & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFMD | DHY |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | 384 | N/A |
| Industry | Medical/Nursing Services | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.1M | 240.4M |
| IPO Year | N/A | 1998 |
| Metric | LFMD | DHY |
|---|---|---|
| Price | $3.82 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.14 | N/A |
| AVG Volume (30 Days) | 679.7K | ★ 809.9K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.52 | N/A |
| Revenue Next Year | $18.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.60 | $1.72 |
| 52 Week High | $7.32 | $2.13 |
| Indicator | LFMD | DHY |
|---|---|---|
| Relative Strength Index (RSI) | 43.13 | 48.24 |
| Support Level | $3.39 | $1.73 |
| Resistance Level | $4.19 | $2.05 |
| Average True Range (ATR) | 0.25 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 42.63 | 35.71 |
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.